Aldo Di Blasi

Nini Hospital, Ospedale di Rivoli

Papers

2

Total Citations

4

H-Index

2

About

Aldo Di Blasi is a urologic surgeon and researcher advancing precision in the surgical management of kidney and prostate cancers. His work centers on refining minimally invasive techniques and personalizing operative strategies to optimize oncologic and functional outcomes. In a landmark 2025 study, Di Blasi pioneered the use of CT-derived signatures to guide reconstructive strategy during off-clamp minimally invasive partial nephrectomy, moving beyond traditional nephrometry scores to directly inform closure techniques—a contribution that promises to improve renal function preservation. His comparative effectiveness research on localized prostate cancer has provided critical early evidence (2-year follow-up) on the outcomes of high-intensity focused ultrasound, cryoablation, and robot-assisted radical prostatectomy, helping to tailor treatment selection for patients with low- to intermediate-risk disease. Though his most cited works are recent, their dual-institutional, prospective design signals a commitment to high-impact, translational urologic oncology. Di Blasi’s focus on actionable, imaging-driven surgical planning and head-to-head therapy comparisons positions him as a rising voice in the quest for more individualized, less invasive cancer care.

Research Focus

Key Achievements

2
H-Index
2
Papers
4
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Profiling the Kidney Before the Incision: CT-Derived Signatures Steering Reconstructive Strategy After Off-Clamp Minimally Invasive Partial Nephrectomy
2 citations · 2025
📈 Most Prolific Year: 2025 (2 Papers)
🤝 Key Collaborators: 27
🏛 Institutions: Nini Hospital, Ospedale di Rivoli

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 17 days ago